|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Click here to see latest analysisEndo International Plc reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Endo International Plc – Onconova Therapeutics Inc., Ono Pharmaceutical Co., Ltd. Unsponsored ADR, OPKO Health, Inc. and Omeros Corporation (ONTX-US, OPHLY-US, OPK-US and OMER-US) that have also reported […] (Read more...) The post Endo International Plc :ENL-CA: Earnings Analysis: Q1, 2016 By the Numbers : June 16, 2016 appeared first on CapitalCube.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that the Reference Module in Food Science and the Reference Module in Materials ...
As the information giant looks to focus on financial and legal services, some say it could sell its Intellectual Property & Science unit for 10 times EBITDA, about $3 bills.